Cargando…
Nonvirally Modified Autologous Primary Hepatocytes Correct Diabetes and Prevent Target Organ Injury in a Large Preclinical Model
BACKGROUND: Current gene- and cell-based therapies have significant limitations which impede widespread clinical application. Taking diabetes mellitus as a paradigm, we have sought to overcome these limitations by ex vivo electrotransfer of a nonviral insulin expression vector into primary hepatocyt...
Autores principales: | Chen, Nelson K. F., Wong, Jen San, Kee, Irene H. C., Lai, Siang Hui, Thng, Choon Hua, Ng, Wai Har, Ng, Robert T. H., Tan, Soo Yong, Lee, Shu Yen, Tan, Mark E. H., Sivalingam, Jaichandran, Chow, Pierce K. H., Kon, Oi Lian |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2249706/ https://www.ncbi.nlm.nih.gov/pubmed/18320053 http://dx.doi.org/10.1371/journal.pone.0001734 |
Ejemplares similares
-
Durable engraftment of genetically modified FVIII‐secreting autologous bone marrow stromal cells in the intramedullary microenvironment
por: Lee, Sze Sing, et al.
Publicado: (2018) -
Multidimensional Genome-wide Analyses Show Accurate FVIII Integration by ZFN in Primary Human Cells
por: Sivalingam, Jaichandran, et al.
Publicado: (2016) -
Nonviral Interferon Inducers
por: Merigan, Thomas C., et al.
Publicado: (1970) -
Improvement of Hydrodynamics-Based Gene Transfer of Nonviral DNA Targeted to Murine Hepatocytes
por: Nakamura, Shingo, et al.
Publicado: (2013) -
Nonviral Approaches for Neuronal Delivery of Nucleic Acids
por: Bergen, Jamie M., et al.
Publicado: (2007)